We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLVS
2501
DELISTED
Clovis Oncology, Inc.
CLVS
$92K ﹤0.01%
15,926
+10,840
+213% +$63.5K
RBNC
2502
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$92K ﹤0.01%
3,297
+1,864
+130% +$53.5K
IPAR icon
2503
Interparfums
IPAR
$3.78B
$91K ﹤0.01%
1,260
-505
-29% -$37.3K
MATW icon
2504
Matthews International
MATW
$710M
$91K ﹤0.01%
2,541
-212
-8% -$8.46K
PXLW icon
2505
Pixelworks
PXLW
$41.9M
$91K ﹤0.01%
2,233
+1,932
+642% +$75.8K
RXRX icon
2506
Recursion Pharmaceuticals
RXRX
$1.75B
$91K ﹤0.01%
+2,512
New +$74.3K
SAFE
2507
Safehold
SAFE
$1.1B
$91K ﹤0.01%
901
-985
-52% -$87.4K
SGMO
2508
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$91K ﹤0.01%
7,564
-151
-2% -$1.71K
SQM icon
2509
Sociedad Química y Minera de Chile
SQM
$20.8B
$91K ﹤0.01%
1,918
-638
-25% -$31.4K
TDIV icon
2510
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.44B
$91K ﹤0.01%
+1,583
New +$89K
USPH icon
2511
US Physical Therapy
USPH
$1.24B
$91K ﹤0.01%
786
-715
-48% -$82.2K
SWIR
2512
DELISTED
Sierra Wireless
SWIR
$91K ﹤0.01%
4,800
+2,010
+72% +$31.3K
SNR
2513
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$91K ﹤0.01%
10,386
+17
+0.2% +$117
KLIC icon
2514
Kulicke & Soffa
KLIC
$4.62B
$90K ﹤0.01%
1,466
+680
+87% +$36.6K
SEER icon
2515
Seer Inc
SEER
$121M
$90K ﹤0.01%
2,743
+702
+34% +$27.7K
SIBN icon
2516
SI-BONE Inc
SIBN
$847M
$90K ﹤0.01%
2,842
-175
-6% -$5.66K
GBT
2517
DELISTED
Global Blood Therapeutics, Inc.
GBT
$90K ﹤0.01%
2,569
+1,842
+253% +$71.9K
ALXO icon
2518
ALX Oncology
ALXO
$282M
$89K ﹤0.01%
1,630
+869
+114% +$52K
BV icon
2519
BrightView Holdings
BV
$1.06B
$89K ﹤0.01%
5,518
+2,326
+73% +$40.8K
CVCO icon
2520
Cavco Industries
CVCO
$4.49B
$89K ﹤0.01%
399
-768
-66% -$167K
NWFL icon
2521
Norwood Financial Corp
NWFL
$365M
$89K ﹤0.01%
3,455
+2,551
+282% +$65.2K
REKR icon
2522
Rekor Systems
REKR
$91.8M
$89K ﹤0.01%
+8,760
New +$134K
SLF icon
2523
Sun Life Financial
SLF
$45.7B
$89K ﹤0.01%
1,724
-231
-12% -$12.2K
TRS icon
2524
TriMas Corp
TRS
$1.43B
$89K ﹤0.01%
2,905
-4,010
-58% -$127K
VTVT icon
2525
vTv Therapeutics
VTVT
$136M
$89K ﹤0.01%
971
+702
+261% +$71.1K
99 100
101
102 103

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.